Author

Marc Baumann

University of HelsinkiORCID 0000-0002-2991-889XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Amir Ata SaeiiD· 1 shared Caroline Akemi HeckmaniD· 1 shared Danilo RitziD· 1 shared Ehsan ZangeneiD· 1 shared Elham GholizadehiD· 1 shared Esko M KankuriiD· 1 shared Juho Jalmari MiettineniD· 1 shared Mathias WilhelmiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Amir Ata SaeiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Shifting Beyond Classical Drug Synergy in Combinatorial Therapy through Solubility Alterations

Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau, Danilo Ritz, Juho Jalmari Miettinen, Rabah Soliymani, Marc Baumann, Mathias Wilhelm, Esko M Kankuri, Paul A. Haynes, Caroline Akemi Heckman, Amir Ata Saei, Mohieddin Jafari

This paper introduces CoPISA, a proteomics workflow that identifies combination-specific protein targets in AML, revealing conjunctional targeting mechanisms beyond classical drug synergy.

Nature Communications · Mar 25, 2026Peer-reviewedBiochemistry